Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares Issued
Ratios

Ligand Pharmaceuticals (LGND) Shares Repurchased (2016 - 2020)

Historic Shares Repurchased for Ligand Pharmaceuticals (LGND) over the last 8 years, with Q4 2020 value amounting to $4.7 million.

  • Ligand Pharmaceuticals' Shares Repurchased fell 9425.08% to $4.7 million in Q4 2020 from the same period last year, while for Sep 2021 it was $4.7 million, marking a year-over-year decrease of 9696.51%. This contributed to the annual value of $78.0 million for FY2020, which is 8278.37% down from last year.
  • Per Ligand Pharmaceuticals' latest filing, its Shares Repurchased stood at $4.7 million for Q4 2020, which was down 9425.08% from $73.3 million recorded in Q1 2020.
  • In the past 5 years, Ligand Pharmaceuticals' Shares Repurchased ranged from a high of $181.2 million in Q3 2019 and a low of $502000.0 during Q1 2016
  • Moreover, its 5-year median value for Shares Repurchased was $50.8 million (2018), whereas its average is $59.7 million.
  • In the last 5 years, Ligand Pharmaceuticals' Shares Repurchased skyrocketed by 789920.84% in 2019 and then tumbled by 9425.08% in 2020.
  • Ligand Pharmaceuticals' Shares Repurchased (Quarter) stood at $502000.0 in 2016, then skyrocketed by 291.63% to $2.0 million in 2017, then soared by 3467.7% to $70.1 million in 2018, then increased by 16.82% to $81.9 million in 2019, then tumbled by 94.25% to $4.7 million in 2020.
  • Its Shares Repurchased stands at $4.7 million for Q4 2020, versus $73.3 million for Q1 2020 and $81.9 million for Q4 2019.